Back to Blackstone Inc. Blackstone Inc.

AUTLAUTL
Showing 8 of 19 quarters

Position history for Blackstone Inc.Blackstone Inc.'s holdings in AUTOLUS THERAPEUTICS PLC

Yes. Blackstone holds 20,485,611 shares of AUTL (Autolus Therapeutics), worth $32.8M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Blackstone has held AUTL since Q4 2021, across 19 quarterly 13F filings. AUTL is 0.1% of Blackstone's reported 13F portfolio.

Current Value

$32.8M

Current Shares

20.5M

Total Value Change

-$41.6M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
20.5M
0.0%
$32.8M0.1%$1.60
0
2026-Q1
Unchanged
20.5M
0.0%
$28.3M0.1%$1.62
0
2025-Q4
Unchanged
20.5M
0.0%
$40.8M0.1%$1.97
0
2025-Q3
Unchanged
20.5M
0.0%
$33.4M0.1%$1.59
0
2025-Q2
Unchanged
20.5M
0.0%
$46.7M0.2%$2.31
0
2025-Q1
Unchanged
20.5M
0.0%
$31.8M0.1%$1.66
0
2024-Q4
Unchanged
20.5M
0.0%
$48.1M0.2%$2.21
0
2024-Q3
Unchanged
20.5M
0.0%
$74.4M0.3%$3.63
0

Other major holders of AUTL: WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used